HALO Diagnostics is committed to early-stage disease screening, diagnosis, and care. Learn more about our HALO PathWay™ for prostate to protect patient health and wellbeing.
are diagnosed with prostate cancer1
of prostate biopsies can be avoided using early detection methods2
of invasive over-treatment of prostate cancer can be avoided with early detection3
5-year survival rate when cancer is caught early, compared to those diagnosed in later stages4
1 https://www.who.int/news-room/facts-in-pictures/detail/cancer 2 Cancer.org 3 Biomarkers and MRI for early PCa detection, https://pubmed.ncbi.nim.nih.gov/32897802 4 seer.cancer.gov
Time from screening to diagnosis is faster, accurate, and more convenient, cutting weeks or months down to just days.

While all men are at risk of getting prostate cancer, some are more likely to develop cancer than others. Our genetic tests identify your inherited risks of cancer and other diseases.

Our combined approach to risk assessment, diagnostics, and treatment is empowering early detection to save lives.

Prostate cancer touches many lives but is often treated too late or with overly invasive surgery. HALO has pioneered new treatments that effectively target prostate tumors while protecting healthy tissue to reduce the side effects associated with standard treatment.
Learn About Our Prostate Treatments
The most common prostate disease affecting men are prostate cancer and BPH, both of which can be caught sooner and treated without surgery.
TULSA-PRO & Laser Focal Therapy
Minimally invasive treatments that destroy cancerous prostate tissue without incisions or radiation.
Learn More About TULSA-PRO Learn More About Laser Focal Therapy
TULSA-PRO & Laser Focal Therapy
The same minimally invasive technology can also relieve enlarged-prostate symptoms without incisions or radiation.
CA Bill 632 will allow more men to receive prostate cancer screenings without the worry of healthcare expenses.
The PCF’s recent campaign highlights the disproportionate prostate cancer burden on Black men and the importance of early detection.
Prostate cancer usually does not cause any noticeable symptoms until it has advanced or progressed, which is why early detection is critical.
Find Articles by Topic: Prostate | Breast | Precision Diagnostics | Lifestyle | Genetics | Neuro | Events
Explore the Prostate Program
Minimally invasive focal laser ablation for prostate cancer, invented by Bernadette M. Greenwood, RT(R)(MR)(ARRT), PhD(c) and refined at HALO.
Precision treatment options for benign prostatic hyperplasia (enlarged prostate).
*International experts agree that most focal therapy techniques remain investigational and should be performed under IRB-approved protocol and/or contribute to an IRB-approved registry – the HALO way.